Pro Share Advisors LLC Corcept Therapeutics Inc Transaction History

Pro Share Advisors LLC

  • $39.7 Billion
  • Q3 2024

A detailed history of Pro Share Advisors LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Pro Share Advisors LLC holds 17,107 shares of CORT stock, worth $986,731. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,107
Previous 12,738 34.3%
Holding current value
$986,731
Previous $413,000 91.53%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$29.51 - $46.26 $128,929 - $202,109
4,369 Added 34.3%
17,107 $791,000
Q2 2024

Aug 13, 2024
SELL
$22.21 - $34.48 $86,152 - $133,747
-3,879 Reduced 23.34%
12,738 $413,000
Q1 2024

May 08, 2024
BUY
$21.1 - $27.46 $28,126 - $36,604
1,333 Added 8.72%
16,617 $418,000
Q4 2023

Feb 14, 2024
BUY
$24.82 - $32.88 $70,712 - $93,675
2,849 Added 22.91%
15,284 $496,000
Q3 2023

Nov 13, 2023
SELL
$21.97 - $33.8 $7,975 - $12,269
-363 Reduced 2.84%
12,435 $338,000
Q2 2023

Aug 10, 2023
BUY
$21.44 - $25.15 $321 - $377
15 Added 0.12%
12,798 $284,000
Q1 2023

May 11, 2023
SELL
$19.2 - $24.47 $21,619 - $27,553
-1,126 Reduced 8.1%
12,783 $276,000
Q4 2022

Feb 02, 2023
BUY
$19.95 - $29.96 $38,124 - $57,253
1,911 Added 15.93%
13,909 $282,000
Q3 2022

Nov 04, 2022
SELL
$24.7 - $29.12 $7,978 - $9,405
-323 Reduced 2.62%
11,998 $307,000
Q2 2022

Aug 01, 2022
SELL
$17.33 - $25.3 $128,103 - $187,017
-7,392 Reduced 37.5%
12,321 $292,000
Q1 2022

May 10, 2022
SELL
$16.53 - $25.21 $68,963 - $105,176
-4,172 Reduced 17.47%
19,713 $444,000
Q4 2021

Feb 08, 2022
BUY
$17.1 - $23.34 $150,548 - $205,485
8,804 Added 58.38%
23,885 $473,000
Q3 2021

Nov 12, 2021
SELL
$19.68 - $22.53 $252,947 - $289,578
-12,853 Reduced 46.01%
15,081 $297,000
Q2 2021

Aug 13, 2021
SELL
$19.97 - $24.43 $23,764 - $29,071
-1,190 Reduced 4.09%
27,934 $615,000
Q1 2021

May 14, 2021
BUY
$23.49 - $30.56 $130,651 - $169,974
5,562 Added 23.61%
29,124 $693,000
Q4 2020

Feb 09, 2021
BUY
$16.78 - $27.3 $166,340 - $270,624
9,913 Added 72.63%
23,562 $616,000
Q3 2020

Nov 13, 2020
SELL
$12.46 - $19.98 $14,029 - $22,497
-1,126 Reduced 7.62%
13,649 $238,000
Q2 2020

Aug 03, 2020
BUY
$11.0 - $18.26 $162,525 - $269,791
14,775 New
14,775 $249,000
Q1 2020

May 15, 2020
SELL
$10.11 - $14.04 $159,808 - $221,930
-15,807 Closed
0 $0
Q4 2019

Feb 12, 2020
BUY
$12.06 - $16.96 $27,894 - $39,228
2,313 Added 17.14%
15,807 $191,000
Q3 2019

Nov 12, 2019
BUY
$10.41 - $14.66 $1,499 - $2,111
144 Added 1.08%
13,494 $191,000
Q2 2019

Aug 13, 2019
SELL
$9.78 - $12.76 $2,709 - $3,534
-277 Reduced 2.03%
13,350 $149,000
Q1 2019

May 15, 2019
BUY
$10.03 - $15.71 $3,851 - $6,032
384 Added 2.9%
13,627 $160,000
Q4 2018

Feb 14, 2019
SELL
$11.29 - $17.19 $15,523 - $23,636
-1,375 Reduced 9.41%
13,243 $177,000
Q3 2018

Nov 14, 2018
SELL
$12.27 - $15.65 $16,417 - $20,939
-1,338 Reduced 8.39%
14,618 $205,000
Q2 2018

Aug 13, 2018
BUY
$15.3 - $19.69 $20,670 - $26,601
1,351 Added 9.25%
15,956 $251,000
Q1 2018

May 14, 2018
SELL
$14.59 - $25.5 $26,305 - $45,976
-1,803 Reduced 10.99%
14,605 $240,000
Q4 2017

Feb 14, 2018
BUY
$15.77 - $20.72 $258,754 - $339,973
16,408
16,408 $296,000

Others Institutions Holding CORT

# of Institutions
347
Shares Held
86.6M
Call Options Held
1.12M
Put Options Held
667K
View Full List

About CORCEPT THERAPEUTICS INC

CORT Quotes by TradingView
  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $6.18B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email